Skip to main content

Research Repository

Advanced Search

Novel tyrosyl-DNA phosphodiesterase 1 inhibitors enhance the therapeutic impact of topoteсan on in vivo tumor models

Zakharenko, A.L.; Luzina, O.A.; Sokolov, D.N.; Kaledin, V.I.; Nikolin, V.P.; Popova, N.A.; Patel, J.; Zakharova, O.D.; Chepanova, A.A.; Zafar, A.; Reynisson, J.; Leung, E.; Leung, I.K.H.; Volcho, K.P.; Salakhutdinov, N.F.; Lavrik, O.I.

Authors

A.L. Zakharenko

O.A. Luzina

D.N. Sokolov

V.I. Kaledin

V.P. Nikolin

N.A. Popova

J. Patel

O.D. Zakharova

A.A. Chepanova

A. Zafar

E. Leung

I.K.H. Leung

K.P. Volcho

N.F. Salakhutdinov

O.I. Lavrik



Citation

Zakharenko, A., Luzina, O., Sokolov, D., Kaledin, V., Nikolin, V., Popova, N., …Lavrik, O. (2019). Novel tyrosyl-DNA phosphodiesterase 1 inhibitors enhance the therapeutic impact of topoteсan on in vivo tumor models. European Journal of Medicinal Chemistry, 161, 581-593. https://doi.org/10.1016/j.ejmech.2018.10.055

Journal Article Type Article
Publication Date 2019-01
Deposit Date Jun 14, 2023
Journal European Journal of Medicinal Chemistry
Print ISSN 0223-5234
Publisher Elsevier
Peer Reviewed Peer Reviewed
Volume 161
Pages 581-593
DOI https://doi.org/10.1016/j.ejmech.2018.10.055
Keywords Organic Chemistry; Drug Discovery; Pharmacology; General Medicine
Additional Information This article is maintained by: Elsevier; Article Title: Novel tyrosyl-DNA phosphodiesterase 1 inhibitors enhance the therapeutic impact of topoteсan on in vivo tumor models; Journal Title: European Journal of Medicinal Chemistry; CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.ejmech.2018.10.055; Content Type: article; Copyright: © 2018 Elsevier Masson SAS. All rights reserved.

You might also like



Downloadable Citations